Susquehanna International Group
IMVT icon

Susquehanna International Group’s Immunovant IMVT Stock Holding History

Susquehanna International Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Buy
617,807
+358,690
+138% +$9.29M ﹤0.01% 2539
2025
Q4 		$6.59M Buy
259,117
+14,893
+6% +$332K ﹤0.01% 3612
2025
Q3 		$3.94M Buy
244,224
+138,931
+132% +$2.25M ﹤0.01% 4500
2025
Q2 		$1.68M Buy
105,293
+17,766
+20% +$269K ﹤0.01% 6166
2025
Q1 		$1.5M Sell
87,527
-158,123
-64% -$3.31M ﹤0.01% 6223
2024
Q4 		$6.08M Buy
245,650
+50,343
+26% +$1.43M ﹤0.01% 3308
2024
Q3 		$5.57M Buy
195,307
+73,615
+60% +$2.17M ﹤0.01% 3435
2024
Q2 		$3.21M Sell
121,692
-121,951
-50% -$3.47M ﹤0.01% 4185
2024
Q1 		$7.87M Buy
243,643
+44,931
+23% +$1.64M ﹤0.01% 2966
2023
Q4 		$8.37M Buy
198,712
+82,376
+71% +$3.03M ﹤0.01% 2885
2023
Q3 		$4.47M Buy
116,336
+98,521
+553% +$2.23M ﹤0.01% 3736
2023
Q2 		$338K Sell
17,815
-124,214
-87% -$2.32M ﹤0.01% 9195
2023
Q1 		$2.2M Buy
142,029
+120,780
+568% +$2.1M ﹤0.01% 4932
2022
Q4 		$377K Buy
21,249
+8,385
+65% +$106K ﹤0.01% 8545
2022
Q3 		$72K Sell
12,864
-7,554
-37% -$36.9K ﹤0.01% 11970
2022
Q2 		$80K Sell
20,418
-64,913
-76% -$280K ﹤0.01% 11659
2022
Q1 		$470K Sell
85,331
-88,680
-51% -$552K ﹤0.01% 9153
2021
Q4 		$1.48M Sell
174,011
-85,172
-33% -$703K ﹤0.01% 6245
2021
Q3 		$2.25M Buy
259,183
+9,412
+4% +$84.9K ﹤0.01% 5574
2021
Q2 		$2.64M Buy
249,771
+207,373
+489% +$2.9M ﹤0.01% 5309
2021
Q1 		$680K Buy
42,398
+25,043
+144% +$660K ﹤0.01% 8745
2020
Q4 		$802K Sell
17,355
-247
-1% -$11.4K ﹤0.01% 7214
2020
Q3 		$619K Buy
+17,602
New +$529K ﹤0.01% 7229

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Susquehanna International Group's IMVT Position: Q1 2026 in Review

Susquehanna International Group increased its Immunovant (IMVT) stake by 138% in Q1 2026, buying an estimated $9.29M and bringing the position to 617,807 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Susquehanna International Group first reported a position in IMVT in Q3 2020 and has held it in 23 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Susquehanna International Group held 617,807 shares of Immunovant worth $15.3M as of Q1 2026.
  • Susquehanna International Group bought 358,690 Immunovant shares in Q1 2026, an estimated $9.29M.
  • Immunovant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2539 holding.
  • Susquehanna International Group first reported a position in Immunovant in Q3 2020 and has held it in 23 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.